Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
Clinical trial NCT06446388 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06446388
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-30
- Primary completion
- 2026-06-30
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.